Machine learning explainability in nasopharyngeal cancer survival using LIME and SHAP
annif.suggestions | forecasts|cancerous diseases|patients|machine learning|surgical treatment|predictability|response to treatment|mortality|diagnosis|papillomaviruses|en | en |
annif.suggestions.links | http://www.yso.fi/onto/yso/p3297|http://www.yso.fi/onto/yso/p678|http://www.yso.fi/onto/yso/p8357|http://www.yso.fi/onto/yso/p21846|http://www.yso.fi/onto/yso/p842|http://www.yso.fi/onto/yso/p9701|http://www.yso.fi/onto/yso/p794|http://www.yso.fi/onto/yso/p5003|http://www.yso.fi/onto/yso/p14134|http://www.yso.fi/onto/yso/p11689 | en |
dc.contributor.author | Alabi, Rasheed Omobolaji | |
dc.contributor.author | Elmusrati, Mohammed | |
dc.contributor.author | Leivo, Ilmo | |
dc.contributor.author | Almangush, Alhadi | |
dc.contributor.author | Mäkitie, Antti A. | |
dc.contributor.faculty | fi=Tekniikan ja innovaatiojohtamisen yksikkö|en=School of Technology and Innovations| | - |
dc.contributor.orcid | https://orcid.org/0000-0001-9304-6590 | - |
dc.contributor.organization | fi=Vaasan yliopisto|en=University of Vaasa| | |
dc.date.accessioned | 2024-02-23T06:11:53Z | |
dc.date.accessioned | 2025-06-25T13:11:24Z | |
dc.date.available | 2024-02-23T06:11:53Z | |
dc.date.issued | 2023-06-02 | |
dc.description.abstract | Nasopharyngeal cancer (NPC) has a unique histopathology compared with other head and neck cancers. Individual NPC patients may attain different outcomes. This study aims to build a prognostic system by combining a highly accurate machine learning model (ML) model with explainable artificial intelligence to stratify NPC patients into low and high chance of survival groups. Explainability is provided using Local Interpretable Model Agnostic Explanations (LIME) and SHapley Additive exPlanations (SHAP) techniques. A total of 1094 NPC patients were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database for model training and internal validation. We combined five different ML algorithms to form a uniquely stacked algorithm. The predictive performance of the stacked algorithm was compared with a state-of-the-art algorithm—extreme gradient boosting (XGBoost) to stratify the NPC patients into chance of survival groups. We validated our model with temporal validation (n = 547) and geographic external validation (Helsinki University Hospital NPC cohort, n = 60). The developed stacked predictive ML model showed an accuracy of 85.9% while the XGBoost had 84.5% after the training and testing phases. This demonstrated that both XGBoost and the stacked model showed comparable performance. External geographic validation of XGBoost model showed a c-index of 0.74, accuracy of 76.7%, and area under curve of 0.76. The SHAP technique revealed that age of the patient at diagnosis, T-stage, ethnicity, M-stage, marital status, and grade were among the prominent input variables in decreasing order of significance for the overall survival of NPC patients. LIME showed the degree of reliability of the prediction made by the model. In addition, both techniques showed how each feature contributed to the prediction made by the model. LIME and SHAP techniques provided personalized protective and risk factors for each NPC patient and unraveled some novel non-linear relationships between input features and survival chance. The examined ML approach showed the ability to predict the chance of overall survival of NPC patients. This is important for effective treatment planning care and informed clinical decisions. To enhance outcome results, including survival in NPC, ML may aid in planning individualized therapy for this patient population. | - |
dc.description.notification | © The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. | - |
dc.description.reviewstatus | fi=vertaisarvioitu|en=peerReviewed| | - |
dc.format.bitstream | true | |
dc.format.content | fi=kokoteksti|en=fulltext| | - |
dc.format.extent | 14 | - |
dc.identifier.olddbid | 19991 | |
dc.identifier.oldhandle | 10024/16934 | |
dc.identifier.uri | https://osuva.uwasa.fi/handle/11111/1659 | |
dc.identifier.urn | URN:NBN:fi-fe202402238456 | - |
dc.language.iso | eng | - |
dc.publisher | Springer Nature | - |
dc.relation.doi | 10.1038/s41598-023-35795-0 | - |
dc.relation.funder | K. Albin Johassons Stifelse | - |
dc.relation.funder | The Sigrid Jusélius Foundation | - |
dc.relation.funder | The Finnish Cancer Society | - |
dc.relation.funder | Finska Läkaresällskapet | - |
dc.relation.funder | Maritza and Reino Salonen Foundation | - |
dc.relation.funder | The Helsinki University Hospital Research Fund | - |
dc.relation.funder | The Turku University Hospital Fund | - |
dc.relation.ispartofjournal | Scientific Reports | - |
dc.relation.issn | 2045-2322 | - |
dc.relation.issue | 1 | - |
dc.relation.url | https://doi.org/10.1038/s41598-023-35795-0 | - |
dc.relation.volume | 13 | - |
dc.rights | CC BY 4.0 | - |
dc.source.identifier | WOS:001000613900003 | - |
dc.source.identifier | Scopus:85160896655 | - |
dc.source.identifier | https://osuva.uwasa.fi/handle/10024/16934 | |
dc.subject | LONG-TERM | - |
dc.subject | Tongue cancer | - |
dc.subject | Outcomes | - |
dc.subject | Metastasis | - |
dc.subject | Intensity-modulated radiotherapy | - |
dc.subject | Staging system | - |
dc.subject | Barr-virus dna | - |
dc.subject | classification | - |
dc.subject | Carcinoma incidence | - |
dc.subject | Toxicities | - |
dc.subject.discipline | fi=Tietoliikennetekniikka|en=Telecommunications Engineering| | - |
dc.title | Machine learning explainability in nasopharyngeal cancer survival using LIME and SHAP | - |
dc.type.okm | fi=A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä|en=A1 Peer-reviewed original journal article|sv=A1 Originalartikel i en vetenskaplig tidskrift| | - |
dc.type.publication | article | - |
dc.type.version | publishedVersion | - |
Tiedostot
1 - 1 / 1
Ladataan...
- Name:
- Osuva_Alabi_Elmusrati_Leivo_Almangush_Mäkitie_2023.pdf
- Size:
- 1.41 MB
- Format:
- Adobe Portable Document Format
- Description:
- Artikkeli